To the content
4 . 2015

Atherosclerosis treatment: choice of optimal statin type

Abstract

Atherosclerosis and its complications in many respects define morbidity patterns in Russia and hold the lead as a cause of death. At the present time atorvastatin (Lipitor) has the most important evidentiary basis as respects to clinical outcomes in patients with different locations of atherosclerosis. Strong lipid-lowering potential, pleiotropic features, large amount of approved indications and favourable safety profile in comorbide patients make it irreplaceable drug for treatment of all atherosclerosis forms.

Keywords:atherosclerosis, treatment, atorvastatin, statins

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)

CHIEF EDITOR
CHIEF EDITOR
Andrey G. Obrezan
MD, Professor, Head of the Hospital Therapy Department of the Saint Petersburg State University, Chief Physician of SOGAZ MEDICINE Clinical Group, St. Petersburg, Russian Federation

Journals of «GEOTAR-Media»